CAPTRUST Financial Advisors’s Cantel Medical Corporation CMD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-294	Closed	-$23K	–	4806
2021 Q1	$23K	Buy	294 +219	+292%	+$17.1K	﹤0.01%	2925
2020 Q4	$6K	Buy	75 +35	+88%	+$2.05K	﹤0.01%	2807
2020 Q3	$2K	Buy	+40	New	+$1.97K	﹤0.01%	2840
2019 Q4	–	Sell	-456	Closed	-$34K	–	1983
2019 Q3	$34K	Sell	456 -10	-2%	-$848	﹤0.01%	1130
2019 Q2	$38K	Sell	466 -18	-4%	-$1.27K	﹤0.01%	1076
2019 Q1	$32K	Buy	484 +183	+61%	+$13.9K	﹤0.01%	1028
2018 Q4	$22K	Buy	301 +71	+31%	+$5.86K	﹤0.01%	999
2018 Q3	$21K	Sell	230 -80	-26%	-$7.62K	﹤0.01%	991
2018 Q2	$30K	Buy	310 +116	+60%	+$13K	﹤0.01%	836
2018 Q1	$21K	Sell	194 -56	-22%	-$6.28K	﹤0.01%	826
2017 Q4	$26K	Buy	+250	New	+$24.9K	﹤0.01%	726

CAPTRUST Financial Advisors's CMD Position: Q2 2021 in Review

CAPTRUST Financial Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 294 shares — an estimated $23K sold.

CAPTRUST Financial Advisors first reported a position in CMD in Q4 2017 and held it in 11 quarters. The position peaked at $38K in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

CAPTRUST Financial Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 294 Cantel Medical Corporation shares in Q2 2021, an estimated $23K.
CAPTRUST Financial Advisors first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 11 quarters.
CAPTRUST Financial Advisors's Cantel Medical Corporation position peaked at $38K in Q2 2019.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.